# The FluSmart experience

## Related work

### News

[January 8, 2026] **Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research**  
[Read](https://press@evidation.com/resources/evidation-launches-temporal-proteomics-platform-and-autoimmune-cohort)

[December 16, 2025] **Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals**  
[Read](https://press@evidation.com/resources/real-world-glp-1-dosing-behaviors)

[December 2, 2025] **Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer**  
[Read](https://press@evidation.com/resources/evidation-appoints-dr-ghazanfar-khan-as-chief-medical-officer)

# What we’ve been up to

[Using Real RWD to Better Understand and Engage Neuro Patients](https://press@evidation.com/resources/the-flusmart-experience#)
  
  
[Predictors of Seeking Care for Influenza-Like Illness in a Novel Digital Study](https://press@evidation.com/resources/the-flusmart-experience#)
  
  
[Evidation is a 2023 Best Place to Work!](https://press@evidation.com/resources/the-flusmart-experience#)

## Related Therapeutic Areas:

[Influenza](https://press@evidation.com/therapeutic-area/influenza)

[**Subscribe to our monthly business newsletter**](https://press@evidation.com/for-customers/newsletter-sign-up)

[Influenza](https://press@evidation.com/therapeutic-area/influenza)

[Download app](https://evidation.onelink.me/5G69/persb)